246 related articles for article (PubMed ID: 30207185)
1. An update on the discovery and development of selective heat shock protein inhibitors as anti-cancer therapy.
Olotu F; Adeniji E; Agoni C; Bjij I; Khan S; Elrashedy A; Soliman M
Expert Opin Drug Discov; 2018 Oct; 13(10):903-918. PubMed ID: 30207185
[TBL] [Abstract][Full Text] [Related]
2. Traditional and Novel Computer-Aided Drug Design (CADD) Approaches in the Anticancer Drug Discovery Process.
Del Carmen Quintal Bojórquez N; Campos MRS
Curr Cancer Drug Targets; 2023; 23(5):333-345. PubMed ID: 35792126
[TBL] [Abstract][Full Text] [Related]
3. Heat Shock Protein (HSP) Drug Discovery and Development: Targeting Heat Shock Proteins in Disease.
Shrestha L; Bolaender A; Patel HJ; Taldone T
Curr Top Med Chem; 2016; 16(25):2753-64. PubMed ID: 27072696
[TBL] [Abstract][Full Text] [Related]
4. Heat shock proteins in cancer: targeting the 'chaperones'.
Nahleh Z; Tfayli A; Najm A; El Sayed A; Nahle Z
Future Med Chem; 2012 May; 4(7):927-35. PubMed ID: 22571616
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein antagonists in early stage clinical trials for NSCLC.
Hendriks LEL; Dingemans AC
Expert Opin Investig Drugs; 2017 May; 26(5):541-550. PubMed ID: 28274158
[TBL] [Abstract][Full Text] [Related]
6. Heat Shock Proteins (HSPs): A Novel Target for Cancer Metastasis Prevention.
Narayanankutty V; Narayanankutty A; Nair A
Curr Drug Targets; 2019; 20(7):727-737. PubMed ID: 30526455
[TBL] [Abstract][Full Text] [Related]
7. Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach.
Chatterjee S; Burns TF
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914774
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Novel HSP27 Inhibitors as Prospective Anti-Cancer Agents Utilizing Computer-Assisted Therapeutic Discovery Approaches.
Umar HI; Ajayi AT; Mukerjee N; Aborode AT; Hasan MM; Maitra S; Bello RO; Alabere HO; Sanusi AA; Awolaja OO; Alshehri MM; Chukwuemeka PO; Aljarba NH; Alkahtani S; Malik S; Alexiou A; Ghosh A; Rahman MH
Cells; 2022 Aug; 11(15):. PubMed ID: 35954254
[TBL] [Abstract][Full Text] [Related]
9. Expediting the Design, Discovery and Development of Anticancer Drugs using Computational Approaches.
Basith S; Cui M; Macalino SJY; Choi S
Curr Med Chem; 2017; 24(42):4753-4778. PubMed ID: 27593958
[TBL] [Abstract][Full Text] [Related]
10. The promise of heat shock protein inhibitors in the treatment of castration resistant prostate cancer.
Ischia J; Saad F; Gleave M
Curr Opin Urol; 2013 May; 23(3):194-200. PubMed ID: 23385973
[TBL] [Abstract][Full Text] [Related]
11. TRAP1: a viable therapeutic target for future cancer treatments?
Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
[TBL] [Abstract][Full Text] [Related]
12. Heat shock proteins in oncology: diagnostic biomarkers or therapeutic targets?
Khalil AA; Kabapy NF; Deraz SF; Smith C
Biochim Biophys Acta; 2011 Dec; 1816(2):89-104. PubMed ID: 21605630
[TBL] [Abstract][Full Text] [Related]
13. Recent Trends in Computer-aided Drug Design for Anti-cancer Drug Discovery.
Razia IT; Kanwal A; Riaz HF; Malik A; Ahsan M; Khan MS; Raza A; Sabir S; Sajid Z; Khan MF; Tahir RA; Sehgal SA
Curr Top Med Chem; 2023; 23(30):2844-2862. PubMed ID: 38031798
[TBL] [Abstract][Full Text] [Related]
14. In silico drug design strategies for discovering novel tuberculosis therapeutics.
Canales CSC; Pavan AR; Dos Santos JL; Pavan FR
Expert Opin Drug Discov; 2024 Apr; 19(4):471-491. PubMed ID: 38374606
[TBL] [Abstract][Full Text] [Related]
15. Computer-aided drug discovery strategies for novel therapeutics for prostate cancer leveraging next-generating sequencing data.
Zhang W; Huang RS
Expert Opin Drug Discov; 2024 Jul; 19(7):841-853. PubMed ID: 38860709
[TBL] [Abstract][Full Text] [Related]
16. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors.
Zaarur N; Gabai VL; Porco JA; Calderwood S; Sherman MY
Cancer Res; 2006 Feb; 66(3):1783-91. PubMed ID: 16452239
[TBL] [Abstract][Full Text] [Related]
17. Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift.
Usha T; Shanmugarajan D; Goyal AK; Kumar CS; Middha SK
Curr Top Med Chem; 2017; 17(30):3296-3307. PubMed ID: 29295698
[TBL] [Abstract][Full Text] [Related]
18. BET inhibitors in cancer therapeutics: a patent review.
Ghoshal A; Yugandhar D; Srivastava AK
Expert Opin Ther Pat; 2016; 26(4):505-22. PubMed ID: 26924192
[TBL] [Abstract][Full Text] [Related]
19. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
20. Molecular simulations required to target novel and potent inhibitors of cancer invasion.
Lu T; Li T; Wu MK; Zheng CC; He XM; Zhu HL; Li L; Man RJ
Expert Opin Drug Discov; 2023; 18(12):1367-1377. PubMed ID: 37676052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
